Sean Moloughney12.17.09
WellGen, Inc., North Brunswick, NJ, and RFI Ingredients, Blauvelt, NY, have signed a Memorandum of Understanding (MOU) that covers a range of areas for cooperation.
The new partnership is designed to enhance the business of both companies and bring new natural products to the market. Products will have a strong base in science, solid clinical support and affirmed GRAS (Generally Recognized as Safe) status.
The MOU serves as a framework for collaboration on several high-growth opportunities: the creation of new medical foods for people with inflammation-related diseases for which there are major unmet needs; the creation of new dietary supplement and functional food products for consumer and healthcare professional markets; and the development and supply of natural ingredients with strong scientific and clinical support.
Commenting on the new relationship, Dr. Roddy Carter, president and CEO of WellGen, stated, “The complementary skills of WellGen and RFI Ingredients will work synergistically to enhance the companies’ natural product offerings. Both companies have been acknowledged for their innovation and share a common interest in developing proprietary, high-quality products supported by strong clinical evidence. This collaboration will couple WellGen’s scientific and clinical know-how with RFI’s infrastructure and expertise in the natural products market.“
“The proprietary research that WellGen has been conducting over the past four years combined with RFI’s innovative ingredients and superior approach to sourcing will provide a significant competitive advantage for both companies as we pursue parallel market opportunities,” stated RFI CEO/president and founder Jeff Wuagneux.
The new partnership is designed to enhance the business of both companies and bring new natural products to the market. Products will have a strong base in science, solid clinical support and affirmed GRAS (Generally Recognized as Safe) status.
The MOU serves as a framework for collaboration on several high-growth opportunities: the creation of new medical foods for people with inflammation-related diseases for which there are major unmet needs; the creation of new dietary supplement and functional food products for consumer and healthcare professional markets; and the development and supply of natural ingredients with strong scientific and clinical support.
Commenting on the new relationship, Dr. Roddy Carter, president and CEO of WellGen, stated, “The complementary skills of WellGen and RFI Ingredients will work synergistically to enhance the companies’ natural product offerings. Both companies have been acknowledged for their innovation and share a common interest in developing proprietary, high-quality products supported by strong clinical evidence. This collaboration will couple WellGen’s scientific and clinical know-how with RFI’s infrastructure and expertise in the natural products market.“
“The proprietary research that WellGen has been conducting over the past four years combined with RFI’s innovative ingredients and superior approach to sourcing will provide a significant competitive advantage for both companies as we pursue parallel market opportunities,” stated RFI CEO/president and founder Jeff Wuagneux.